The present invention relates to compounds of the formula ##STR00001## methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.

 
Web www.patentalert.com

< RAF inhibitors and their uses

> Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols

> Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome
~ 00556